Background Health-related quality of life and survival are two important outcome measures
in cancer research and practice. The aim of this paper is to examine the relationship …

Abstract Treatment options in multiple myeloma (MM) are increasing with the introduction of
complex multi-novel-agent-based regimens investigated in randomized clinical trials …

Objectives Multiple myeloma (MM) is an incurable haematological disease. Due to novel
agents, overall survival has improved in this group, yet there are no systematic reviews to …

Background Multiple myeloma, the second most common haematological cancer, remains
incurable. Its incidence is rising due to population ageing. Despite the impact of the disease …

The aim of this study is to examine the impact of haematological cancers on quality of life
(QoL). A review of the international literature was conducted from the databases …

As the prognosis for multiple myeloma (MM) has significantly improved and patients remain
on therapy longer, there is a need for supportive care interventions to optimize patient …

Introduction Treatment advances in multiple myeloma have increased expected survival
from months to years for some patients. Alongside improved survival emerges a need to …

Quality of life in elderly patients with acute myeloid leukemia: patients may be more accurate
than physicians - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

BACKGROUND Multiple myeloma (MM) is the second most common haematological cancer
in the UK. MM is not curable but can be treated with a combination of supportive measures …

Background: Patients with multiple myeloma, an incurable haematological cancer, often
receive palliative care only late in their trajectory. Criteria for early referral are lacking. Aim …